Phase I-IIA Clinical Trials
INC Research/inVentiv Health conducts Phase I-IIa clinical trials quickly and efficiently at its dedicated 22,000 square foot clinical facility comprising more than 200 beds in four independent units. An extensive database and relationships with leading hospitals ensures rapid recruitment of study participants for a wide variety of trials.
INC Research/inVentiv Health conducts Phase I-IIa clinical trials quickly and efficiently at its dedicated 22,000 square foot clinical facility comprising more than 200 beds in four independent units. An extensive database and relationships with leading hospitals ensures rapid recruitment of study participants for a wide variety of trials.
In addition to a staff of eight physicians and a dedicated project manager for each study, we deploy a team of experts, including specialists in quality assurance, and scientific and regulatory affairs, to custom fit a program to your specific needs. Accordingly, advanced equipment, skilled staff, meticulous material handling, and timely reporting of our bioanalytical laboratories ensure the smooth completion of projects.
Our departments and business processes, including data processing and report writing, comply with current GCP and GLP standards, while an independent quality-assurance unit validates study data and reports, providing the basis for our exceptional regulatory success. With a full range of services from study design to submission, inVentiv Health provides everything you need to efficiently conduct your study.